Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression. (2025). Journal of Analytical Oncology, 14, 49-61. https://doi.org/10.30683/1927-7229.2025.14.09